Multi-dose pre-clinical studies in RAT for E1-targeting antisense oligonucleotides

Ended Project Grant Awarded Last action

Award ID
R43NS113643
Recipient
Awarding agency
Obligated
$228,113

Award facts

Assistance listing
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders
Completion date
Place of performance
Columbia, MO 65203, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Original award $228,113

Quick answers

Who received award R43NS113643?

R43NS113643 was awarded to Shift Pharmaceuticals Holdings, Inc. by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on September 16, 2019.

How much is award R43NS113643 worth?

$228,113 has been obligated on R43NS113643.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award